BriaCell Therapeutics Corp. CEO William Williams' 2023 pay jumps 50% to $1.2M
BriaCell Therapeutics Corp. reports 2023 executive compensation
By ExecPay News
Published: January 9, 2024
BriaCell Therapeutics Corp. reported fiscal year 2023 executive compensation information on January 9, 2024.
In 2023, four executives at BriaCell Therapeutics Corp. received on average a compensation package of $731K, a 67% increase compared to previous year.
William V. Williams, Chief Executive Officer, received $1.2M in total, which increased by 50% compared to 2022. 61% of Williams' compensation, or $737K, was in salary. Williams also received $49K in non-equity incentive plan, $307K in option awards, as well as $123K in stock awards.
Giuseppe Del Priore, Chief Medical Officer, received a compensation package of $949K, which increased by 128% compared to previous year. 49% of the compensation package, or $467K, was in salary.
Gadi Levin, Chief Financial Officer, earned $391K in 2023, a 53% increase compared to previous year.
Miguel A. Lopez-Lago, Chief Scientific Officer, received $368K in 2023, which increases by 37% compared to 2022.
BriaCell Therapeutics Corp.'s fiscal year ends on July 31.